Aspire-Lakewood Holdings, Inc. (ASBP) Executive Compensation
Aspire-Lakewood Holdings, Inc. (ASBP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ASBP
CIK: 1847345
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Turner, Stone & Company, L.L.P.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMatthew Kundert
Audit LocationDallas, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-24 | 8-K | 0001493152-26-044908 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-08 | 8-K | 0001493152-26-041918 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001493152-26-041725 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-19 | 8-K | 0001493152-26-039135 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005317 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037819 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-10 | — | SCHEDULE 13G Filing | 0001213900-26-087424 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-06 | 8-K | 0001493152-26-036777 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0001493152-26-036445 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | 8-K | 0001493152-26-033942 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-02 | — | SCHEDULE 13G Filing | 0002142929-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-16 | 8-K | 0001493152-26-029599 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-09 | 8-K | 0001493152-26-028518 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-12 | 8-K | 0001493152-26-028386 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023802 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000919574-26-003204 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-11 | 8-K | 0001493152-26-023069 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-055622 | View SEC Doc Filr Page |
| DEFR14A | 2026-05-12 | — | DEFR14A | 0001493152-26-022511 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-08 | 2026-05-08 | DEF 14A | 0001493152-26-022026 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-27 | 2026-04-27 | PRE 14A | 0001493152-26-019171 | View SEC Doc Filr Page |
| 8-K | 2026-04-20 | 2026-04-20 | 8-K | 0001493152-26-018018 | View SEC Doc Filr Page |
| 8-K/A | 2026-04-17 | 2026-04-15 | 8-K/A | 0001493152-26-017145 | View SEC Doc Filr Page |
| 8-K | 2026-04-16 | 2026-04-15 | 8-K | 0001493152-26-017115 | View SEC Doc Filr Page |
| 8-K | 2026-04-16 | 2026-04-10 | 8-K | 0001493152-26-017054 | View SEC Doc Filr Page |